Abbott Lab- Brief introduction
Abbott Laboratories is one of the largest providers and manufacturers of medical devices and healthcare products. It has its headquarters in Abbott Park, Illinois, USA.
Contact Details: 16th Floor, Godrej BKC, Plot – C, “G” Block, Bandra-Kurla Complex, Bandra (East), Mumbai – 400 051, India
Tel: +91-22-5046 1000 / 2000
Abbott India is a division of the global healthcare company Abbott. It was established in India in 1910 and is now one of the country’s leading healthcare companies. The company offers a range of healthcare products and services, including diagnostics, nutrition, pharmaceuticals, medical devices, and more.
Abbott Laboratories, a subsidiary of Abbott Pharmaceuticals, Inc., is a leader in developing, manufacturing, and selling pharmaceuticals and medical devices. It is a pioneer in researching and developing new products and services for the health and well-being of people worldwide. The company has a reach in 160+ countries and 103K employees worldwide. (logo rights reserved with Abbot Laboratories).
About Abbott India Limited
Abbott India is committed to advancing healthcare for all. It has worked to improve access to healthcare for people across the country. The company has also been involved in many initiatives to improve the healthcare system in India, such as providing free heart surgeries for children in need and launching the Abbott India Health Equity Program to ensure equitable access to healthcare for all 5.
It is India’s fastest-growing pharmaceutical company. The company is helping India to live a healthier life since 1910. Abbott offers various products, including diagnostic tools, nutritional products, branded generic pharmaceuticals, and vascular/diabetes devices. Abbott India Limited has its headquarters in Mumbai. It is a subsidiary of Abbott Laboratories and is publicly listed.
The range of medicines includes primary care, women’s health, cardiology, gastroenterology, metabolic disorders, etc.
Abbott India: Board of Directors
- Munir Shaikh – Chairman
- Anil Joseph – Managing Director
- Anisha Motwani – Independent Director
- Sudarshan Jain – Independent Director
- Shalini Kamath – Independent Director
- Ambati Venu – Non-Executive Director
- Kaiyomarz Marfatia – Non-Executive Director
- Rajiv Sonalker – Whole-time Director
Therapeutic Categories:
Abbott offers formulations in various therapeutic areas, such as neuro-Psychiatric, pain management, respiratory women’s health, hepatic, neuroscience, metabolic, vaccine, gen-next, consumer care, and gastroenterology.
Brands:
The brands associated with the company are Similac, Pediasure, Pedialyte, Elecare, zone perfect, Ensure, FreeStyle Libre, and Glucerna.
| Brand | Composition | Details |
|---|---|---|
| ACTRAPID | INSULIN HUMAN BASE RECOMBINANT | |
| CREMAFFIN PLUS | MAGNESIUM HYDROXIDE + PARAFFIN OIL + PICOSULFURIC ACID DISODIUM |  |
| DUPHASTON | DYDROGESTERONE |  |
| EPTOIN | PHENYTOIN SODIUM SALT |  |
| INFLUVAC | VACCINE, INFLUENZA INACTIVATED |  |
| KENACORT | TRIAMCINOLONE ACETONIDE |  |
| LOBATE-GM NEO | CHLOROCRESOL + CLOBETASOL PROPIONATE + MICONAZOLE NITRATE + NEOMYCIN SULFATE |  |
| MIXTARD | INSULIN HUMAN BASE RECOMBINANT + INSULIN HUMAN ISOPHANE RECOMBINANT |  |
| NOVO RAPID | INSULIN ASPART RECOMBINANT |  |
| NOVOFINE | DISPOSABLE MEDICAL DEVICES |  |
| NOVOMIX | INSULIN ASPART PROTAMINE CRYSTALLINE RECOMBINANT + INSULIN ASPART RECOMBINANT |  |
| PHENSEDYL COUGH | CHLORPHENAMINE MALEATE + CODEINE PHOSPHATE |  |
| RYZODEG | INSULIN ASPART RECOMBINANT + INSULIN DEGLUDEC RECOMBINANT |  |
| STEMETIL | PROCHLORPERAZINE DIMALEATE |  |
| THYRONORM | LEVOTHYROXINE SODIUM |  |
| UDILIV | URSODEOXYCHOLIC ACID |  |
| VERTIN | BETAHISTINE HYDROCHLORIDE |  |
Market Performance:
In 2019, the company’s worldwide sales were $31.9B, with organic sales growth of 33%. The adjusted earnings per share per growth was 12.5%. Abbott India Ltd.’s key Products/Revenue Segments include Injectables which contributed 40.97 % of Total Sales, Tablets which contributed 38.64 % of Total Sales, Liquids which contributed 13.93 % of Total Sales, Capsules which added 3.54 % of Total Sales, Service Income which added 0.59 % of Total Sales, and Ointments which added 0.43 % of Total Sales. It reported a standalone revenue of $1.1 billion, or $0.01 per share (quarter ended March 31, 2020). Revenue of about $2.2 billion is reported for the first quarter of 2019.
Incorporates in the Year:
2016:
- Abbott has been awarded the Shingo Prize for operational excellence.
2017:
- The company was among the top 10 businesses on Fast Company’s list.
- National Association for Female executive has named Abbott the top company for executive women.
2019:
- Listed as number 158 on the Forbes Global 2000 list of the world’s largest companies based on revenues.
Pingback: Pharmaceutical Content Writing: How can I learn this skill? - PharmaCampus
Pingback: Pharma News Update – 6 August 2020 > PharmaCampus